Pennsylvania consumers who purchased certain generic prescription drugs between May 2009 and December 2019 may be eligible for compensation under a newly opened settlement claims process. The Pennsylvania generic drug settlement follows multiple national settlements involving manufacturers accused of conspiring to raise prices and reduce competition. The Pennsylvania Attorney General’s Office is urging consumers to check the eligible-drug list and file a claim if they qualify. A federal court has preliminarily approved a plan to distribute settlement funds.
What Is the Pennsylvania Generic Drug Settlement?
The Pennsylvania generic drug settlement is part of a multistate legal effort involving allegations of anticompetitive conduct in the generic pharmaceutical industry. Antitrust laws are designed to protect competition and prevent businesses from coordinating in ways that can harm consumers.
Pennsylvania and a coalition of 47 other states and territories pursued claims against generic drug manufacturers. The settlements currently being distributed total approximately $96.5 million, involving Glenmark, Lannett, Bausch, Apotex, Heritage and Heritage’s parent company, Emcure.
The Pennsylvania Attorney General’s Office said about $25 million to $30 million in consumer restitution funds has been recovered so far, with additional settlement money expected.
Who Is Eligible for the Generic Drug Settlement Claim?
The Pennsylvania generic drug settlement eligibility depends on both the medication purchased and when it was purchased. Consumers who bought a qualifying generic prescription drug during the covered period may be eligible.
The list includes commonly prescribed generic versions of medicines such as:
- Albuterol
- Cipro
- Prednisone
- Levothyroxine
Consumers should check the official settlement drug list rather than assume that every generic medication qualifies.
How to File a Generic Drug Settlement Claim?
Consumers eligible for the Pennsylvania generic drug settlement claim can use the official claims process to determine whether they qualify for the generic drug settlement payout.
The generic drug settlement claim process involves:
- Check the qualifying drug list for the prescription purchased.
- Confirm the purchase period, which generally covers May 2009 through December 2019.
- Review the available claim options and provide the requested information.
- Submit the claim before the deadline.
Consumers may not need an old medicine receipt to file. The claim process can allow consumers to report an estimate of qualifying out-of-pocket payments, although supporting records such as insurance information may be needed.
The current deadline for this Pennsylvania generic drug settlement claims process is March 8, 2027. Consumers can check eligibility and file through AGGenericDrugs.com, or contact the claims administrator at 1-866-290-0182 or info@AGGenericDrugs.com.
How Much Could the Generic Drug Settlement Payout Be?
There is no fixed payment amount for every claimant. The amount available to an eligible consumer can depend on the settlement funds, qualifying purchases, and the distribution process.
The Pennsylvania Attorney General has not announced a guaranteed individual payout.
Consumers should therefore avoid websites that promise a specific payment before their claim has been reviewed.
Bottom Line
The generic drug lawsuit settlement in USA resolves allegations involving specific manufacturers; it does not mean that every company named in the broader litigation has settled or that every allegation has been finally determined.
The Pennsylvania Attorney General’s Office said the broader antitrust cases began in 2016 and involve different groups of drugs and defendants. Some litigation remains ongoing.
For eligible consumers, checking the official drug list and submitting a valid generic drug settlement claim before March 8, 2027 are the key steps to seek compensation.
